Patents by Inventor Wouter POS

Wouter POS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-TDP-43 ANTIBODIES AND USES THEREOF
    Publication number: 20260176307
    Abstract: Provided herein are antibodies and polypeptides that specifically bind to TDP-43. Also provided are pharmaceutical compositions comprising these antibodies, polynucleotides encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
    Type: Application
    Filed: March 3, 2026
    Publication date: June 25, 2026
    Inventors: Pavlina KONSTANTINOVA, Sander VAN DEVENTER, Wouter POS, Svitlana PASTEUNING-VUHMAN
  • DEGRON FUSION CONSTRUCTS
    Publication number: 20250235558
    Abstract: Provided herein are degrons, compositions, and chimeric molecules comprising the degrons, and methods of using the degrons and chimeric molecules.
    Type: Application
    Filed: December 20, 2024
    Publication date: July 24, 2025
    Inventors: Barbara Sanders, Wouter Pos, Pavlina Konstantinova, Sander van Deventer, Menno Spits
  • RECOMBINANT AAV CAPSID PROTEINS
    Publication number: 20250115643
    Abstract: Provided herein are recombinant adeno-associated virus (AAV) capsid proteins, compositions (e.g., rAAV) comprising the capsid proteins, nucleic acids encoding the capsid proteins, and methods of making and using the capsid proteins.
    Type: Application
    Filed: December 16, 2024
    Publication date: April 10, 2025
    Inventors: Barbara Sanders, Wouter Pos, Pavlina Konstantinova, Sander van Deventer
  • RECOMBINANT AAV CAPSID PROTEINS
    Publication number: 20250025579
    Abstract: Provided herein are recombinant adeno-associated virus (AAV) capsid proteins, compositions (e.g., rAAV) comprising the capsid proteins, nucleic acids encoding the capsid proteins, and methods of making and using the capsid proteins.
    Type: Application
    Filed: October 4, 2024
    Publication date: January 23, 2025
    Inventors: Barbara Sanders, Wouter Pos, Pavlina Konstantinova, Sander Van Deventer
  • Therapeutic Anti-CD9 Antibody
    Publication number: 20240360239
    Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.
    Type: Application
    Filed: April 24, 2024
    Publication date: October 31, 2024
    Inventors: Hergen SPITS, Paula Maria Wilhelmina VAN HELDEN, Remko SCHOTTE, Wouter POS, Christien FATMAWATI, Danïel Michiel GO, Koen WAGNER, Julien Christian VILLAUDY
  • Therapeutic anti-CD9 antibody
    Patent number: 11999793
    Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.
    Type: Grant
    Filed: September 16, 2021
    Date of Patent: June 4, 2024
    Assignee: Kling Biotherapeutics B.V.
    Inventors: Hergen Spits, Paula Maria Wilhelmina Van Helden, Remko Schotte, Wouter Pos, Christien Fatmawati, Danïel Michiel Go, Koen Wagner, Julien Christian Villaudy
  • AML ANTIGENS AND USES THEREOF
    Publication number: 20230235018
    Abstract: The present invention provides novel compounds comprising an antigen of AML cells, and uses thereof.
    Type: Application
    Filed: October 27, 2022
    Publication date: July 27, 2023
    Inventors: Hergen SPITS, Marijn Aletta GILLISSEN, Martijn KEDDE, Mette Deborah HAZENBERG, Paula Maria Wilhelmina VAN HELDEN, Wouter POS
  • AML antigens and uses thereof
    Patent number: 11524989
    Abstract: The present invention provides novel compounds comprising an antigen of AML cells, and uses thereof.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: December 13, 2022
    Assignee: KLING BIOTHERAPEUTICS B.V.
    Inventors: Hergen Spits, Marijn Aletta Gillissen, Martijn Kedde, Mette Deborah Hazenberg, Paula Maria Wilhelmina van Helden, Wouter Pos
  • Therapeutic Anti-CD9 Antibody
    Publication number: 20220064323
    Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.
    Type: Application
    Filed: September 16, 2021
    Publication date: March 3, 2022
    Inventors: Hergen SPITS, Paula Maria Wilhelmina VAN HELDEN, Remko SCHOTTE, Wouter POS, Christien FATMAWATI, Danïel Michiel GO, Koen WAGNER, Julien Christian VILLAUDY
  • Therapeutic anti-CD9 antibody
    Patent number: 11136407
    Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: October 5, 2021
    Assignee: AIMM Therapeutics B.V.
    Inventors: Hergen Spits, Paula Maria Wilhelmina Van Helden, Remko Schotte, Wouter Pos, Christien Fatmawati, Danïel Michiel Go, Koen Wagner, Julien Christian Villaudy
  • Therapeutic Anti-CD9 Antibody
    Publication number: 20190023803
    Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.
    Type: Application
    Filed: January 6, 2017
    Publication date: January 24, 2019
    Applicant: AIMM Therapeutics B.V.
    Inventors: Hergen SPITS, Paula Maria Wilhelmina VAN HELDEN, Remko SCHOTTE, Wouter POS, Christien FATMAWATI, Danïel Michiel GO, Koen WAGNER, Julien Christian VILLAUDY
  • AML ANTIGENS AND USES THEREOF
    Publication number: 20180170998
    Abstract: The present invention provides novel compounds comprising an antigen of AML cells, and uses thereof.
    Type: Application
    Filed: June 24, 2016
    Publication date: June 21, 2018
    Inventors: Hergen SPITS, Marijn Aletta GILLISSEN, Martijn KEDDE, Mette Deborah HAZENBERG, Paula Maria Wilhelmina van HELDEN, Wouter POS